Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia
about
Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cellsThe omptins of Yersinia pestis and Salmonella enterica cleave the reactive center loop of plasminogen activator inhibitor 1Fibrinolytic and coagulative activities of Yersinia pestisCauses and consequences of coagulation activation in sepsis: an evolutionary medicine perspectiveFibrinolytic and procoagulant activities of Yersinia pestis and Salmonella enterica.Hemodynamic Correlates of Abnormal Aortic Root Dimension in an Adult Population: The Strong Heart StudyThrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice.CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia.Hematopoietic but not endothelial cell MyD88 contributes to host defense during gram-negative pneumonia derived sepsis.Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsisPlasminogen activator inhibitor-type I gene deficient mice show reduced influx of neutrophils in ventilator-induced lung injuryKinase activity profiling of gram-negative pneumonia.Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) MiceReceptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia.Critical role of type 1 plasminogen activator inhibitor (PAI-1) in early host defense against nontypeable Haemophilus influenzae (NTHi) infection.Recent insight into potential acute respiratory distress syndromeAMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-β-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.PAI-1 inhibits neutrophil efferocytosis.Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injuryPlasminogen activator inhibitor-1 does not contribute to the pulmonary pathology induced by acute exposure to ozone.Intracellular and extracellular serpins modulate lung disease.Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host.Substrates of the plasminogen activator protease of Yersinia pestis.Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity.Plasminogen activator inhibitor-1 regulates LPS-induced TLR4/MD-2 pathway activation and inflammation in alveolar macrophages.Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulenceSERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in miceRole of triggering receptor expressed on myeloid cells-1/3 in Klebsiella-derived pneumosepsis.Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.Platelet and endothelial cell P-selectin are required for host defense against Klebsiella pneumoniae-induced pneumosepsis.Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation.Transgenic tissue-type plasminogen activator expression improves host defense during Klebsiella pneumonia.Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).Systemic inhibition and liver-specific over-expression of PAI-1 failed to improve survival in all-inclusive populations or homogenous cohorts of CLP micePAI-1 inhibits development of chronic otitis media and tympanosclerosis in a mouse model of otitis media
P2860
Q24317592-AC468D4A-7B76-4997-82F5-1553E9C9517CQ24612107-2D460B83-BCA7-4DCF-995D-5F53FDE3E59FQ26862503-37BF4FA5-0C9A-4827-9DAC-C4F22D3C0CE1Q26995417-010D123D-34AB-4BEB-83E0-47BD451E47F7Q30152900-CF175845-6F5C-419B-B0E3-C9A1A100CDB2Q30385080-CFE793AC-F444-4F5D-8980-3E0D29EC6168Q33418094-D7A524E8-DC55-450C-8A07-CB5AEBBF1414Q34254524-0921E3BB-F00E-45E7-9A1F-ACDBCE2FE211Q34257461-8B29520C-250C-411F-9591-1EC577FDD10CQ34468940-AF666742-F0D0-4BE8-8F26-DACBAEA4296BQ35119519-787157B8-D04C-4214-AAE3-B58455280942Q35136658-9D695CD5-F86F-496D-9BB1-C2B5258118E1Q35664945-8868898D-14E9-41BC-B996-A546A541F99EQ35908548-9EDC1652-D2B2-4F98-B50B-7C4C3106818DQ35990134-4BBACC30-FA65-4D6A-B80C-D190C45E9BF7Q36342998-B451B979-40A3-4A71-A3DF-DDEEFB9C4D57Q36666173-0B8B15E5-7F06-4E61-87B0-25D5842D8E0DQ36954409-8AA623A3-0DF4-47DA-8571-908E38D07C69Q37138889-97263FC6-9BA2-47AB-A000-54E3B1DBE81CQ37286847-DF4E8077-0470-4D31-942F-AE4BFCCA74E0Q37341652-4EC039A8-7E94-4931-9890-08F2DF7FA879Q38005762-C0A81C45-5B76-43AF-BC44-ADAA7A369692Q38025359-A1F2D813-9E51-493E-9025-90C77499B52AQ38612236-D7276FA1-1E18-4261-BC54-D3FB1DA4E447Q38945452-1E95E211-76AF-44B8-8567-6E6604959FEAQ39633118-8E2474D3-E8E1-4574-9E39-546A784E1733Q40470944-71FD444E-9491-438D-BCFB-FA9C8C22BFAEQ41261629-8E99D8EE-EEF5-4B9A-8912-9A5A42A1DB16Q41346626-AC75085F-2E41-467F-B2DE-3D45E04A40D5Q41428336-C7235704-D276-41E3-8CF3-AC0B61E7433EQ41430104-9CCBB4CC-5FB1-401B-9C2F-CC0716049702Q41826464-D6638D58-6F28-482A-986F-05CF39778B22Q51703244-FE88AC10-9F96-4777-89DE-B80348DA1689Q51719546-85620BC2-5A06-4148-B190-94B921265AB8Q55057343-274DE643-F9CB-4F7A-B77A-C63243E351C7Q58106436-EEF95013-3328-476E-B316-6F639578621DQ58296855-EA4D1C71-FBA4-4496-B010-70B781C29B38
P2860
Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@ast
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en-gb
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@nl
type
label
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@ast
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en-gb
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@nl
prefLabel
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@ast
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en-gb
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@nl
P2093
P50
P921
P3181
P1433
P1476
Plasminogen activator inhibito ...... severe Gram-negative pneumonia
@en
P2093
Carlie J M de Vries
Cornelis van't Veer
Joris J T H Roelofs
Marcel Levi
Peter I Bonta
Rosemarijn Renckens
P304
P3181
P356
10.1182/BLOOD-2006-05-025197
P407
P577
2007-02-15T00:00:00Z